Live tumour board workspaceThoracic · Neuro · Breast · GI · Heme · Multi-Organ

Every caseleaves the roomdecided.

OncoBoard MDT is where multidisciplinary tumour boards prepare, review and decide. The dossier is complete before the meeting. Every specialist reads the same slice during it. The signed recommendation is on file before the next case loads.

30 minutes, onlineYour boards and rolesDe-identified sample case

Why this exists

Cancer care is decided in one meeting. The tools in it were built for something else.

Researchers sat in on 96 lung cancer MDT meetings across eight teams in one UK cancer network. They found inefficiencies in every one of them.

24%

of case discussions ended with the decision deferred, most often because results were still pending.

21%

of meetings observed were fully quorate. Palliative care was the specialty most often missing.

60%

of cases discussed had fitness or performance status information available, ranging from 30% to 75% by team.

Source: Zasada et al., Cancer Medicine, 2023. 8 lung MDTs, 96 meetings, 12 weeks.Read the studyNHS England streamlining guidance, 2020

The same board, two Tuesdays.

NHS England's 2020 guidance asks teams to give full discussion to complex cases and manage the rest against agreed standards of care. That only works if each case arrives prepared and leaves recorded.

    Organ Tumour Boards

    Six boards.
    Six different questions.

    Each board opens with the imaging window, staging and markers it actually argues about. Run one board or every board, on one record per case. Explore every board

    01 / 06
    Thoracic Oncology01

    Resect, irradiate, or target first?

    For stage III disease the answer turns on mediastinal nodes, a driver mutation and PD-L1. They sit on one screen beside the CT, already windowed for lung.

    Opens with
    CT · Lung −600 / 1500
    Staging
    AJCC TNM · ECOG
    Markers
    EGFRALKROS1KRAS G12CMET ex14PD-L1 TPS
    Neuro Oncology02

    One integrated diagnosis.

    Since WHO CNS5 in 2021, the molecular result is part of the diagnosis. Histology, IDH, 1p/19q and MGMT arrive together, so nobody decides on half a report.

    Opens with
    MRI · Brain
    Grading
    WHO CNS5 integrated
    Markers
    IDH1/21p/19qMGMTCDKN2A/BH3 K27M
    Breast Oncology03

    HER2-zero or HER2-low?

    Receptor status splits more ways than it used to. ER, PR, the HER2 score, Ki-67 and germline results sit next to the breast MRI before neoadjuvant or surgical options are weighed.

    Opens with
    MRI · Breast
    Staging
    AJCC TNM · grade
    Markers
    ERPRHER2 IHC/ISHKi-67BRCA1/2PIK3CA
    GI Oncology04

    Resectable, borderline, or not yet?

    With liver metastases the surgeon asks first. The liver window, calibrated measurements, mismatch repair status and RAS/BRAF are on screen when the question comes.

    Opens with
    CT · Liver 60 / 160
    Staging
    AJCC TNM · CEA trend
    Markers
    dMMR / MSI-HKRASNRASBRAF V600EHER2
    Heme Oncology05

    Response, risk, and the next line.

    Lymphoma boards read PET-CT against the Deauville scale. Leukaemia boards weigh ELN 2022 risk. Both get imaging, cytogenetics and molecular results in one dossier.

    Opens with
    PET-CT
    Frameworks
    Lugano · ELN 2022
    Markers
    Deauville 1–5NPM1FLT3-ITDTP53MYC / BCL2
    Multi-Organ Board06

    When the primary isn't obvious.

    Unknown primary, oligometastatic disease and second primaries need every specialty at once. The Multi-Organ board brings every preset and every marker set to one agenda.

    Opens with
    Any clinical preset
    Staging
    Per primary
    Markers
    All boardsNGS Tier I–III

    Workflow

    One case.
    Intake to signed.

    Follow ONC-2026-4102, a 64-year-old with right upper lobe adenocarcinoma, through a Thoracic Board. Every panel below is interactive. See the full platform

    01 · Prepare

    Register once. Arrive complete.

    The coordinator enters MRN, initials, board and urgency. TNM resolves to an AJCC stage group. Pathology, IHC, NGS and trial matches attach to the same case, so nothing is chased by email the night before.

    • MRN and initials only. The case record has no field for a full name.
    • Routine, Priority and Urgent triage against a 72-hour SLA.
    Case Registry · Thoracic 4 of 18 cases
    ONC-2026-4102 · R.K.
    T2b N2 M0 · Stage IIIA · ECOG 1
    Priority
    ONC-2026-4110 · F.N.
    KRAS G12C · second line
    Urgent
    ONC-2026-4093 · S.H.
    ALK fusion · restaging
    In Review
    ONC-2026-4087 · M.A.
    T1c N0 M0 · Stage IA3
    Consensus Reached
    Histology
    Adenocarcinoma · G2
    PD-L1
    65% TPS
    EGFR · Tier I-A
    p.Leu858Arg · 31.8%
    Trials
    2 eligible · 1 screen
    02 · Present

    One slice on every screen.

    The radiologist drives the study. Every connected clinician follows the same slice, window and measurement in real time. Target lesions are measured once, calibrated, and saved to the case.

    • Six clinical presets: lung, soft tissue, mediastinum, bone, brain, liver.
    • Upload a DICOM series or open the study already on the case.
    Live Board Room 06:42
    CT Chest · Slice 42 / 96
    WL 40 · WW 400
    Presenter
    Diagnostic Radiology
    Hover to read HU
    MOSORODRMPCO6 connected
    03 · Decide

    Every specialty, on the record.

    Each specialty votes with its rationale. Quorum is met at three specialties and the whole room can see it. Dissent is kept with the case instead of disappearing with the meeting.

    • Live quorum before the chair can ratify.
    • Votes stored by specialty, with time and rationale.
    Specialty votes · ONC-2026-4102
    0 / 3
    Specialties · Pending
    04 · Record

    Signed before the next case loads.

    AI drafts the minutes from the votes and discussion. The chair edits, signs off and exports the consensus report for the EHR. Each step is written to the audit log with who and when.

    • AI drafts are labelled and need a human sign-off.
    • Consensus report exported per case.
    AI-Drafted Minutes · edited by Chair

    Case. 64-year-old, right upper lobe adenocarcinoma, AJCC T2b N2 M0, Stage IIIA, ECOG 1. EGFR p.Leu858Arg, PD-L1 65% TPS.

    Recommendation. Multistation N2, not for upfront resection. Concurrent chemoradiation, then osimertinib consolidation. Restage CT at 12 weeks.

    Votes. 5 of 5 specialties in favour. No dissent recorded.

    AI decision support. Review and edit before ratifying.

    Consensus signed and exportedONC-2026-4102_MDT_Consensus_Report.txt

    Roles

    Built for every
    seat at the table.

    Six specialties come to a tumour board with six different jobs. OncoBoard gives each one the view it needs, on the same case.

    AI Decision Support

    AI drafts.
    Clinicians decide.

    Four assistants do the reading and writing a board never has time for. None of them can vote, sign off or change the record. How the AI works

    Case synthesis

    A one-page brief of staging, pathology, molecular drivers and open questions, ready before the meeting starts.

    Slice read

    A structured read of the current DICOM slice as a second look for the radiologist, never a replacement.

    Consensus minutes

    Minutes drafted from the votes and discussion for the chair to edit and sign.

    Case copilot

    Plain-language questions answered from the dossier in front of the board.

    Every output labelled "AI Decision Support"
    Every output ends with a disclaimer
    Cannot vote, sign off or edit the record
    Prompted with the case dossier only
    Case CopilotONC-2026-4102 · Thoracic Board

    AI decision support. Verify against source records before use.

    Clinical Analytics

    Know how long
    a decision takes.

    Turnaround from intake to consensus, by board and by urgency, against your SLA. Export any view as CSV for the governance meeting. Analytics in detail

    Cases this quarter
    148
    Across six boards
    Intake to consensus
    52h avg
    Target 72 h
    Urgent turnaround
    31h avg
    Urgent triage only
    Consensus Reached
    91%
    Of cases discussed

    Average turnaround by board

    Hours from intake to Consensus Reached

    Example data for illustration.

    Security & governance

    Patient data,
    handled like it matters.

    Your information governance team will ask these questions first. Here are the answers. Read the security overview

    De-identified by design

    Cases carry an MRN and initials. The case record has no field for a full name, date of birth or address.

    ONC-2026-4102 · R.K.

    Hashed credentials

    Passwords are salted per user, hashed with scrypt and compared in constant time.

    scrypt · 16-byte salt · 64-byte key

    Short-lived sessions

    Sessions expire after 12 hours and are revoked at sign-out.

    256-bit random bearer token

    Everything on the record

    Registrations, measurements, votes and sign-offs write to an audit log with who did what and when.

    Audit & Database view for IT

    AI inside clear limits

    Assistants draft and answer. Only a clinician can vote, ratify or edit the record.

    Labelled · disclaimed · human sign-off

    Runs where you choose

    OncoBoard runs on Node.js and MySQL, so it can be deployed on infrastructure your governance team approves.

    Node.js · MySQL · WebSocket sync

    FAQ

    Asked in
    every demo.

    Does OncoBoard replace our PACS?
    No. It reads DICOM in the browser for board review: windowing, slice navigation and calibrated measurements. Primary diagnostic reporting stays on your PACS workstation.
    We already meet on Teams or Zoom. Do we stop?
    Keep your call for audio and video. OncoBoard handles what a screen share can't: one synced slice for everyone, the dossier, the votes and the signed record.
    Do patient names ever enter the system?
    Cases are identified by MRN and initials, and the case record has no field for a full name. Uploaded DICOM files are read in your browser and not sent to the server, but their headers can still carry a name, so upload de-identified exports.
    Can the AI make or change a decision?
    No. Every AI output is labelled and ends with a disclaimer. The assistants draft summaries, slice reads and minutes, and answer questions. Voting, ratifying and editing the record are clinician actions only.
    What is on record after a case is discussed?
    Each specialty's vote with its rationale, the ratified recommendation, the minutes, any RECIST measurements and an audit trail. The consensus report exports per case for your EHR.
    How does the demo work?
    Thirty minutes, online. We set up your boards and roles in a sandbox and run a de-identified sample case from intake to a signed consensus report, with your team driving.

    Bring one real board. We'll run it with you.

    A 30-minute session, online, with the people who sit on your board.

    1. 01We set up your boards, roles and clinicians in a sandbox.
    2. 02Your coordinator registers a de-identified sample case.
    3. 03Your team presents, votes and signs it off, live.
    Boards you run

    Design preview. Submitting here sends nothing.

    Request recorded.

    Design preview. Nothing was sent.